The Genetic Target: How Fibrodysplasia Ossificans Progressiva Therapy is Advancing with Gene-Based Innovations
Fibrodysplasia ossificans progressiva (FOP) is one of the rarest and most disabling genetic disorders, characterized by the progressive formation of heterotopic bone in soft tissues, effectively turning muscles and connective tissue into a second skeleton. This devastating condition, caused by mutations in the ACVR1 gene, has long been without effective treatment. The Fibrodysplasia...
0 Commenti 0 condivisioni 105 Views 0 Anteprima